Respiratory Disease Summaries Flashcards
Asthma
chronic inflammatory condition of the large and small airways that causes episodic exacerbations of bronchoconstriction
Asthma signs/symptoms
- Diurnal variability. Typically, worse at night and early morning
- Dry cough (Non-productive) with wheeze and shortness of breath
- A history of other atopic conditions such as eczema, hayfever and food allergies
- Associated atopy ↑IgE ( rhinitis , conjunctivitis, eczema)
Asthma management
- SABA
- Inhaled Corticosteroid e.g. beclometason
- LABA e.g. salmeterol
- Oral leukotriene antagonist, oral B2 agonist, oral theophylline or inhaled LAMA
- Titrate inhaled steroid
- Add in oral steroids
Omalizumab
inhibits the binding to the high-affinity IgE receptor which inhibits TH2 response and associated mediator release from basophils/mast cells
ABGs asthma
Initially patients will have a respiratory alkalosis as tachypnoea causes a drop in CO2.
A normal pCO2 or hypoxia is a concerning sign as it means they are tiring and indicates life threatening asthma.
A respiratory acidosis due to high CO2 is a very bad sign in asthma.
Grading PEFR
Moderate: 50-75%
Severe: 33-50%
Life-threating: under 33%
Acute asthma management
- O - oxygen - high flow 100%
- S - salbutamol -Nebulised
- H - hydrocortisone - given IV
- I - ipratropium Bromide IV
- T - theophylline
- M - magnesium Sulphate
- AN – anaesthetist
COPD
• Chronic obstructive pulmonary disease (COPD) is a non-reversible, long term deterioration in air flow through the lungs caused by damage to lung tissue.
Chronic bronchitis and emphysema
COPD investigations
Spirometry: >0.75% and no reversibility to salbutamol <15%
- Full blood count for polycythaemia or anaemia. Polycythaemia (raised haemoglobin) is a response to chronic hypoxia.
- Baseline BMI to assess weight loss (e.g. cancer or severe COPD) or weight gain (e.g. steroids).
- Sputum culture to assess for chronic infections such as pseudomonas.
- ECG and echocardiogram to assess heart function.
- CT thorax for alternative diagnoses such as fibrosis, cancer or bronchiectasis.
- Serum alpha-1 antitrypsin to look for alpha-1 antitrypsin deficiency
COPD management
- beta-2 agonists
- No asthmatic or steroid responsive features: combined long-acting beta agonist (LABA) plus a long acting muscarinic antagonist
Or
Asthmatic or steroid responsive features: combined long acting beta agonist (LABA) plus an inhaled corticosteroid (ICS).
- LABA, LAMA and ICS e..g trimbo
Exacerbation of COPD
Acute worsening of symptoms such as cough, shortness of breath, sputum production and wheeze.
It is usually triggered by a viral or bacterial infection.
o Haemophilus influenzae & Moraxella catarrhalis, Streptococcus pneumoniae, Gram-negatives & others
COPD exacerbation Ix
Chest x-ray to look for pneumonia or other pathology
ECG to look for arrhythmia or evidence of heart strain (heart failure)
FBC to look for infection (raised white cells)
U&E to check electrolytes which can be affected by infection and medications
Sputum culture if significant infection is present
Blood cultures if septic
management of COPD exacerbation
o Nebulised bronchodilators (e.g. salbutamol 5mg/4h and ipratropium 500mcg/6h)
o 24-28% Oxygen titrated against PaO2/PaCO2
o Antibiotics if evidence of infection e.g. amoxicillin or doxycycline
o Steroids (e.g. 200mg hydrocortisone or 30-40mg oral prednisolone)
idiopathic pulmonary fibrosis causes
secondary: o rheumatoid, SLE, systemic sclerosis, asbestos, alpha-1-antitripsin deficiency
,drugs - amiodarone, bleomycin, penicillamine, nitrofurantoin, methotrexate, cyclophosphamide
IPF Investigations
- Restrictive defect on PFT’s - reduced FEV1 and FVC with normal or raised FEV1/FVC ratio, reduced lung volumes, low gas transfer
- CxR - bilateral infiltrates;
- CT scan - reticulonodular fibrotic shadowing, worse at the lung bases, and periphery.
- High resolution CT scan of the thorax – ground glass appearance
IPF management
steroids and immunosuppressants to slow disease down
Pirfenidone: anti-fibrotic and anti-inflammatory
Nintedanib: tyrosine kinase monoclonal antibody
oxygen
lung transplant
Hypersensitivity Pneumonitis (AKA Extrinsic Allergic Alveolitis)
type III hypersensitivity reaction to an environmental allergen . Causes parenchymal inflammation and destruction
allergens: o Bird-fanciers lung is a reaction to bird droppings (avian proteins)
o Farmers lung is a reaction to mouldy spores in hay (thermophilic bacteria)
o Mushroom workers’ lung is a reaction to specific mushroom antigens (fungi)
o Malt workers lung is a reaction to mould on barley
Hypersensitivity Pneumonitis (AKA Extrinsic Allergic Alveolitis) signs/symptoms
acute: several hours after acute exposure - cough episodic breathless, fever and myalgia, crackles (no wheeze)
chronic: progressive breathless and cough, may be crackles
Hypersensitivity Pneumonitis (AKA Extrinsic Allergic Alveolitis) investigations
- CxR pulmonary fibrosis - most commonly in the upper zones due to better ventilation of the upper lobes then the lower
- PFTs: restrictive defect (low FEV1 & FVC, high or normal ratio, low gas transfer - TLCO)
- Lung biopsy if in doubt
hypersensitivity pneumonitis management
o2, steroids and antigen avoidance
Cryptogenic Organising Pneumonia
focal area of inflammation of the lung tissue. This can be idiopathic or triggered by infection, inflammatory disorders, medications, radiation or environmental toxins or allergens.
Cryptogenic Organising Pneumonia Mx
steroids
Sarcoidosis
multisystem granulomatous inflammatory condition (type IV hypersensitivity). • Granulomas are nodules of inflammation full of macrophages
sarcoidosis classic triad
- Erythema nodosum
- Bilateral hilar lymphadenopathy
- Polyarthralgia (joint pain in multiple joints)
sarcoidosis diagnosis
Bloods:
o Raised serum ACE (screening)
o Hypercalcaemia
o Raised CRP
o Raised immunoglobulins
o U&Es, LFTS
o Urine dipstick or urine albumin-creatinine ratio to look for proteinuria indicating nephritis
o Ophthalmology
o ECG and echocardiogram for heart involvement
o Ultrasound abdomen for liver and kidney involvement
Imaging
o Chest x-ray shows hilar lymphadenopathy
o High resolution CT thorax shows hilar lymphadenopathy and pulmonary nodules
o MRI can show CNS involvement
o PET scan can show active inflammation in affected areas
• Biopsy: Non-caseating granulomas with epithelioid cells
sarcoidosis management
acute: nothing or oral steroids
chronic: oral steroids, immunosuppression e.g. azathioprine, methotrexate, anti-TNF therapy, lung transplant
asbestosis
lung fibrosis related to the inhalation of asbestos.
o Benign pleural plaques – asymptomatic: usually develop future complications
o Acute asbestos pleuritis - fever, pain, bloody pleural effusion
o Pleural Effusion and Diffuse pleural thickening - restrictive impairment
adenocarcinoma and malignant mesothelioma
Coal workers pneumoconiosis
occupational disease (type of pneumoconiosis) caused by exposure to coal dust free of silica (washed coal).
types of coal workers pneuumoconiosis
Simple pneumoconiosis
o chest X-ray abnormality only
o no impairment of lung function - often associated with chronic obstructive pulmonary disease
Complicated pneumoconiosis
o progressive massive fibrosis - restrictive pattern with breathlessness
Lung cancer types
• Non-small cell lung cancer:
o Squamous cell carcinoma (35%): pink keratin
o Adenocarcinoma (25%): glands mucin – most common with non-smokers
o large cell carcinoma (10%): undifferentiated
Small Cell Lung Cancer (SCLC) (20%)
signs/symptoms of lung cancer
SOB Cough >3 weeks Haemoptysis hoarse voice finger clubbing stridor anaemia unexplained weight loss recurrent pneumonia
lung cancer investigations
FBC, Coagulation screen, Na, K, Ca, Alk Phos
FEV
CXR
CT Scan: lung to adrenal glands
PET-CT scans
management non-small cell lung cancer
surgery: pneumonectomy, lobectomy and segmentectomy
radiotherapy
chemotherapy: adjuvant
small cell lung cancer management
chemotherapy and radiotherapy
mesothelioma
• Lung malignancy affecting the mesothelial cells of the pleura or very occasionally of the lining of the abdominal cavity.
mesothelioma investigations
Imaging: pleural nodularity, pleural thickening, local invasion and lung entrapment
• Aspiration: Low cytological yield and protein > 30 g/L (exudate)
• Investigate if cancer in pleural space is malignant or not
Mesothelioma management
• Pleurodesis: adhere your lung to your chest wall to prevent fluid or air from continually building up around your lungs
o TALC sclerosing agent: minor pleuritic pain and fever
o Long term pleural catheters: malignant effusion
o TS spend longer in hospital and need more rescue procedures
o IPC have more adverse event
• Radiotherapy
• Surgery
• Chemotherapy can improve survival but it is essentially palliative.
Pleural effusion
abnormal collection of fluid in the pleural cavity
Classification of pleural effusion
Exudative: high protein count (>3g/dL)
o Related to inflammation: protein leaks out of the tissues into pleural space (moving out) e.g. Malignancy, pneumonia, RA, trauma and TB
Transudative: lower protein count (<3g/dL).
o Fluid moving across into pleural space e.g. Congestive cardiac failure, hypoalbuminaemia, hypothyroidism, Meig’ syndrome (right sided pleural effusion with ovarian malignancy)
Lights criteria
exudative if
1. fluid protein: serum protein >0.5
- fluid LDH: serum LDH >0.6
- Fluid LDH > 2/3rds normal upper limit of serum LDH
- Fluid cholesterol level is over 45 mg/dl
pleural effusion Iv
CXR: blunting of costophrenic angle and meniscus in larger effusions
Aspiration or chest drain
Pleural effusion management
small effusions can resolve and treat underling cause e.g. heart failure
Larger: aspiration or drainage and chest drain
Empyema
infected pleural effusion